USFDA completes inspection of Strides Pharma Bengaluru plant
Team Udayavani, Jul 20, 2019, 6:13 PM IST
Image for Representation
Bengaluru: Drug firm Strides Pharma Science said on Saturday the inspection of its formulation facility in Bengaluru by the US health regulator has completed successfully with a voluntary action indicated (VAI) classification.
The company’s facility in Bengaluru underwent a United States Food and Drug Administration (USFDA) inspection that ended on May 24, 2019, Strides Pharma Science said in a statement.
The Bengaluru facility is the largest manufacturing facility for the company with capabilities to produce finished dosage formulation products across multiple dosage formats including tablet, capsules, ointments, creams and liquids, Strides Pharma said.
The facility services key regulated markets of the US, Europe, and Australia, it added.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Shivakumar desperately wants to become CM, says K’taka BJP chief Vijayendra
M’luru: Hotelier approaches consumer court after car filled with diesel instead of petrol
CET 2024: At least 45 questions out of syllabus, claim students
Former BJP MLAs Malikayya Guttedar, Sharada Shetty join Congress
‘Out of control’ lorry hits several vehicles, shops after ‘brake failure’ at Yedapadavu
MUST WATCH
Latest Additions
Injuries don’t define you: Mohammed Shami shares rehab update
Shivakumar desperately wants to become CM, says K’taka BJP chief Vijayendra
Scribe throws lapel microphone towards Sharad Pawar in Baramati; cops give clean chit
India delivers first batch of BrahMos missiles to Philippines
Air India cancels Dubai flights due to operational disruptions